These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16121981)

  • 1. Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia.
    Yano A; Shingo T; Takeuchi A; Yasuhara T; Kobayashi K; Takahashi K; Muraoka K; Matsui T; Miyoshi Y; Hamada H; Date I
    J Neurosurg; 2005 Jul; 103(1):104-14. PubMed ID: 16121981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of infarct volume and apoptosis by grafting of encapsulated basic fibroblast growth factor-secreting cells in a model of middle cerebral artery occlusion in rats.
    Fujiwara K; Date I; Shingo T; Yoshida H; Kobayashi K; Takeuchi A; Yano A; Tamiya T; Ohmoto T
    J Neurosurg; 2003 Dec; 99(6):1053-62. PubMed ID: 14705734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume.
    Harrigan MR; Ennis SR; Sullivan SE; Keep RF
    Acta Neurochir (Wien); 2003 Jan; 145(1):49-53. PubMed ID: 12545262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
    Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
    J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contraindications of VEGF-based therapeutic angiogenesis: effects on macrophage density and histology of normal and ischemic brains.
    Manoonkitiwongsa PS; Schultz RL; Whitter EF; Lyden PD
    Vascul Pharmacol; 2006 May; 44(5):316-25. PubMed ID: 16530019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
    Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
    Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia.
    Miki Y; Nonoguchi N; Ikeda N; Coffin RS; Kuroiwa T; Miyatake S
    Neurosurgery; 2007 Sep; 61(3):586-94; discussion 594-5. PubMed ID: 17881973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease.
    Shingo T; Date I; Yoshida H; Ohmoto T
    J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences.
    Winn SR; Lindner MD; Lee A; Haggett G; Francis JM; Emerich DF
    Exp Neurol; 1996 Aug; 140(2):126-38. PubMed ID: 8690056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
    Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
    Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophic factor-secreting cell grafting for cerebral ischemia: preliminary report.
    Fujiwara K; Date I; Shingo T; Yoshida H; Kobayashi K; Takeuchi A; Tamiya T; Ohmoto T
    Cell Transplant; 2001; 10(4-5):419-22. PubMed ID: 11549065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model.
    Yasuhara T; Shingo T; Muraoka K; wen Ji Y; Kameda M; Takeuchi A; Yano A; Nishio S; Matsui T; Miyoshi Y; Hamada H; Date I
    Brain Res; 2005 Mar; 1038(1):1-10. PubMed ID: 15748867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease.
    Yasuhara T; Shingo T; Kobayashi K; Takeuchi A; Yano A; Muraoka K; Matsui T; Miyoshi Y; Hamada H; Date I
    Eur J Neurosci; 2004 Mar; 19(6):1494-504. PubMed ID: 15066146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular Endothelial Growth Factor 165-Binding Heparan Sulfate Promotes Functional Recovery From Cerebral Ischemia.
    Chan SJ; Esposito E; Hayakawa K; Mandaville E; Smith RAA; Guo S; Niu W; Wong PT; Cool SM; Lo EH; Nurcombe V
    Stroke; 2020 Sep; 51(9):2844-2853. PubMed ID: 32772683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts.
    Emerich DF; Plone M; Francis J; Frydel BR; Winn SR; Lindner MD
    Brain Res; 1996 Oct; 736(1-2):99-110. PubMed ID: 8930314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum.
    Emerich DF; Hammang JP; Baetge EE; Winn SR
    Exp Neurol; 1994 Nov; 130(1):141-50. PubMed ID: 7821389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dose-effectiveness of intranasal VEGF in treatment of experimental stroke.
    Yang JP; Liu HJ; Wang ZL; Cheng SM; Cheng X; Xu GL; Liu XF
    Neurosci Lett; 2009 Sep; 461(3):212-6. PubMed ID: 19559076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transplantation of gene-transfected neural stem cells for transient cerebral ischemia in rats].
    Zhu W; Zhou LF; Wang Y; Zhu JH; Mao Y
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1029-34. PubMed ID: 15312541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of VEGF165-gene-transfected endothelial progenitor cells in the treatment of chronic venous thrombosis in rats.
    Meng QY; Li XQ; Yu XB; Lei FR; Jiang K; Li CY
    Chin Med J (Engl); 2010 Feb; 123(4):471-7. PubMed ID: 20193489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat.
    Wang Y; Galvan V; Gorostiza O; Ataie M; Jin K; Greenberg DA
    Brain Res; 2006 Oct; 1115(1):186-93. PubMed ID: 16928361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.